… this exciting new thyroid cancer field. The oncogenic role of TERT promoter mutations involves
… TERT C228T is far more common than TERT C250T and their collective prevalence is, on …

… On the other hand, nine cases of the remaining 129 cases with thyroid cancer were positive
for TERT promoter mutations. C228 mutation was positive in four out of 111 cases of PTC …

… of TERT promoter mutations in follicular cell-derived thyroid carcinomas. … of TERT promoter
mutations in advanced thyroid cancers, as well as a significant co-occurrence with mutations …

… However, the clinical effect of BRAF mutation or TERT promoter mutation alone was modest.
Interestingly, coexisting BRAF V600E and TERT promoter mutations were shown to be …

… demonstrated that TERT-p mutations were also detected in thyroid cancers, especially in …
thyroid carcinoma (PDTC) and anaplastic thyroid carcinoma (ATC) [26, 27]. These mutations …

… patients from Middle East demonstrates that TERT promoter mutations are relatively common,
… features, BRAF V600E mutation, and disease persistence/recurrence than the WT TERT. …

… thyroid cancer share considerably similar genetic backgrounds; for example, they both harbor
the BRAF V600E mutation … to explore TERT promoter mutations in thyroid cancers in the …

… cancer (82.6% vs 99.4% for exclusively BRAF mutation alone; 5.62; 1.85–17.09). In conclusion,
the presence of TERT promoter mutations … patients with differentiated thyroid cancer. The …

… The prevalence of TERT promoter mutations in differentiated thyroid cancer (PTC and
FTC) found in the present study was lower than the generally reported prevalence in primary …

… of thyroid cancer, such as poorly differentiated thyroid cancer … In the present study, we
explored TERT promoter mutations … of thyroid cancer patients to further examine the role of TERT …